ResMed
ResMed is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the healthcare market. The company primarily focuses on the treatment and management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. Its value proposition centers on improving patient outcomes and provider efficiency through connected health technologies and data-driven respiratory care.
Financials
Based on Q1 2026 · FQ3 FY2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Sleep and Respiratory Care Devices
primaryThis segment focuses on the design and manufacture of medical hardware used to treat obstructive sleep apnea and chronic respiratory conditions. It includes continuous positive airway pressure machines and bilevel devices that provide ventilation support.
AirSense, AirCurve, Lumis, AirMini, Astral, Stellar
Home medical equipment providers, Sleep clinics, Hospitals, Retail consumers
Masks and Accessories
majorThis segment provides the essential interfaces and consumables required for effective pressure therapy. It includes a wide range of nasal, full-face, and pillows masks designed for patient comfort and compliance.
AirFit, AirTouch, Swift FX, Mirage
Individual patients, Sleep labs, Distributors
Software as a Service (SaaS)
moderateThis segment provides cloud-based business management and patient monitoring software for out-of-hospital care settings. These solutions help providers manage workflows, billing, and patient compliance tracking.
AirView, myAir, Brightree, MatrixCare
Home health agencies, Hospice providers, Skilled nursing facilities, Durable medical equipment suppliers
Segment Financials
Sleep and Breathing Health — Net revenue
View metricSleep And Breathing Health — R&D
View metricSleep And Breathing Health — Cost of Sales
View metricMasks and other — Net revenue by segment
View metricResidential Care Software — Cost of Sales
View metricResidential Care Software — Net revenue
View metricResidential Care Software — Selling, general, and administrative
View metricBusiness Overview
Competitive Position
ResMed is a dominant global player in the sleep apnea market, characterized by high R&D investment and a massive installed base of cloud-connected devices.
Geographies
North America, Europe, Asia-Pacific, Latin America
Customer Segments
Healthcare Providers, Medical Equipment Distributors, Chronic Disease Patients
Upstream Dependencies
Electronic component manufacturers, Medical-grade plastic suppliers, Cloud infrastructure providers, Logistics and freight services
Downstream Customers
Sleep diagnostic centers, Home medical equipment (HME) providers, Third-party payors, Retail pharmacies
Competitors & Partners
Competitors
Philips
PHG
Primary global competitor in sleep and respiratory care
Inspire Medical Systems
INSP
Competitor offering implantable neurostimulation for sleep apnea
Eli Lilly
LLY
Pharmaceutical competitor via weight-loss drugs impacting OSA demand
Five Point Holdings, Inc.
FPH
Competitor in masks and respiratory humidification
Subsidiaries
Brightree
Provider of cloud-based software for post-acute care
MatrixCare
SaaS solution for long-term care and senior living
Propeller Health
Digital health company for asthma and COPD management
ResMed FAQ
Common questions about ResMed
ResMed is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the healthcare market. The company primarily focuses on the treatment and management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. Its value proposition centers on improving patient outcomes and provider efficiency through connected health technologies and data-driven respiratory care.
ResMed (RMD) has a market capitalization of $29.6B and trades on NYSE.
ResMed generated $5.5B in trailing twelve-month revenue with net income of $1.5B, representing a net margin of 27.4%. Gross margin stands at 61.6%, with free cash flow of $1.8B. These figures are based on the Q1 2026 filing.
ResMed's key competitors include Koninklijke Philips N.V., Inspire Medical Systems, Eli Lilly and Company, and others. These companies compete in similar markets and product categories.
ResMed has approximately 10,140 employees.